Physician profile
Joseph Hackler
NPI 1710151204
$4,335.46
in general payments reported to CMS, 2019-2025
31 companies · $180 in 2025
The $180 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $838 · 2020: $432 · 2021: $952 · 2022: $1,023 · 2023: $408 · 2024: $504 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,091.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,091.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $920.53 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $887.60 | 2019-2025 | |
| Amgen INC. | $316.58 | 2019-2022 | |
| Abbott Laboratories | $230.40 | 2019-2025 | Cardiomems |
| Astrazeneca Pharmaceuticals Lp | $211.67 | 2020-2021 | |
| Pfizer INC. | $175.63 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $155.89 | 2019-2024 | Eliquis, Camzyos |
| Merck Sharp & Dohme LLC | $155.16 | 2021-2023 | Verquvo |
| Boston Scientific Corporation | $148.77 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $146.82 | 2019-2024 | Uptravi, Opsumit |
| Heartflow, INC. | $133.18 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $128.41 | 2019-2023 | Lifevest |
| Abiomed | $124.27 | 2019 | |
| Sanofi-Aventis U.S. LLC | $123.18 | 2019-2023 | |
| Philips North America LLC | $77.00 | 2020-2025 | Ecc Solutions |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $59.43 | 2019-2022 | |
| Baxter Healthcare | $55.54 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Irhythm Technologies, INC. | $50.30 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.32 | 2021 | |
| Portola Pharmaceuticals, LLC | $21.49 | 2019 | |
| Cvrx, INC. | $20.68 | 2025 | Barostim Neo System |
| Alnylam Pharmaceuticals INC. | $19.21 | 2022 | |
| Edwards Lifesciences Corporation | $19.00 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Atricure, INC. | $18.17 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System, Atriclip Laa Exclusion System |
| Lundbeck LLC | $17.71 | 2020 | |
| Cardiva Medical, INC. | $17.48 | 2025 | Cardiva Vascade 6/7f Vcs |
| Kiniksa Pharmaceuticals International, Plc | $16.05 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $15.82 | 2024 | |
| Esperion Therapeutics, INC. | $14.34 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 | |
| Gilead Sciences, INC. | $11.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Hackler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.